These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

403 related items for PubMed ID: 8228190

  • 1. Chronic angiotensin II type 1 receptor antagonism in genetic hypertension: effects on vascular structure and reactivity.
    Oddie CJ, Dilley RJ, Kanellakis P, Bobik A.
    J Hypertens; 1993 Jul; 11(7):717-24. PubMed ID: 8228190
    [Abstract] [Full Text] [Related]

  • 2. Effect of AT1 angiotensin-receptor blockade on structure and function of small arteries in SHR.
    Li JS, Sharifi AM, Schiffrin EL.
    J Cardiovasc Pharmacol; 1997 Jul; 30(1):75-83. PubMed ID: 9268224
    [Abstract] [Full Text] [Related]

  • 3. Role of angiotensin II in early cardiovascular growth and vascular amplifier development in spontaneously hypertensive rats.
    Black MJ, Kanellakis P, Bobik A.
    J Hypertens; 1997 Sep; 15(9):945-54. PubMed ID: 9321741
    [Abstract] [Full Text] [Related]

  • 4. Long-term angiotensin II antagonism in spontaneously hypertensive rats: effects on blood pressure and cardiovascular amplifiers.
    Oddie CJ, Dilley RJ, Bobik A.
    Clin Exp Pharmacol Physiol; 1992 May; 19(5):392-5. PubMed ID: 1387843
    [Abstract] [Full Text] [Related]

  • 5. Cardiac and vascular effects of long-term losartan treatment in stroke-prone spontaneously hypertensive rats.
    Gohlke P, Linz W, Schölkens BA, Wiemer G, Unger T.
    Hypertension; 1996 Sep; 28(3):397-402. PubMed ID: 8794823
    [Abstract] [Full Text] [Related]

  • 6. Role of angiotensin II in the regulation of a novel vascular modulator, hepatocyte growth factor (HGF), in experimental hypertensive rats.
    Nakano N, Moriguchi A, Morishita R, Kida I, Tomita N, Matsumoto K, Nakamura T, Higaki J, Ogihara T.
    Hypertension; 1997 Dec; 30(6):1448-54. PubMed ID: 9403566
    [Abstract] [Full Text] [Related]

  • 7. Persistent cardiovascular effects of chronic renin-angiotensin system inhibition following withdrawal in adult spontaneously hypertensive rats.
    Paull JR, Widdop RE.
    J Hypertens; 2001 Aug; 19(8):1393-402. PubMed ID: 11518847
    [Abstract] [Full Text] [Related]

  • 8. Vascular smooth muscle polyploidy and cardiac hypertrophy in genetic hypertension.
    Dominiczak AF, Devlin AM, Lee WK, Anderson NH, Bohr DF, Reid JL.
    Hypertension; 1996 Mar; 27(3 Pt 2):752-9. PubMed ID: 8613236
    [Abstract] [Full Text] [Related]

  • 9. Enhanced pressor response to angiotensin III in spontaneously hypertensive rats: effects of losartan.
    Radhakrishnan R, Sim MK.
    Eur J Pharmacol; 1994 Jun 23; 259(1):87-90. PubMed ID: 7957599
    [Abstract] [Full Text] [Related]

  • 10. Effects of losartan, a nonpeptide angiotensin II receptor antagonist, on cardiac hypertrophy and the tissue angiotensin II content in spontaneously hypertensive rats.
    Mizuno K, Tani M, Hashimoto S, Niimura S, Sanada H, Watanabe H, Ohtsuki M, Fukuchi S.
    Life Sci; 1992 Jun 23; 51(5):367-74. PubMed ID: 1385640
    [Abstract] [Full Text] [Related]

  • 11. AT1 receptor antagonist treatment caused persistent arterial functional changes in young spontaneously hypertensive rats.
    Gillies LK, Lu M, Wang H, Lee RM.
    Hypertension; 1997 Dec 23; 30(6):1471-8. PubMed ID: 9403569
    [Abstract] [Full Text] [Related]

  • 12. Losartan reduces cardiac mass and improves coronary flow reserve in the spontaneously hypertensive rat.
    Kaneko K, Susic D, Nunez E, Frohlich ED.
    J Hypertens; 1996 May 23; 14(5):645-53. PubMed ID: 8762209
    [Abstract] [Full Text] [Related]

  • 13. Resistance artery mechanics, structure, and extracellular components in spontaneously hypertensive rats : effects of angiotensin receptor antagonism and converting enzyme inhibition.
    Intengan HD, Thibault G, Li JS, Schiffrin EL.
    Circulation; 1999 Nov 30; 100(22):2267-75. PubMed ID: 10578002
    [Abstract] [Full Text] [Related]

  • 14. Molecular mechanism of angiotensin II type I and type II receptors in cardiac hypertrophy of spontaneously hypertensive rats.
    Makino N, Sugano M, Otsuka S, Hata T.
    Hypertension; 1997 Oct 30; 30(4):796-802. PubMed ID: 9336375
    [Abstract] [Full Text] [Related]

  • 15. Relationship between cardiovascular hypertrophy and cardiac baroreflex function in spontaneously hypertensive and stroke-prone rats.
    Minami N, Head GA.
    J Hypertens; 1993 May 30; 11(5):523-33. PubMed ID: 8390524
    [Abstract] [Full Text] [Related]

  • 16. Chronic AT(1) blockade stimulates extracellular collagen type I degradation and reverses myocardial fibrosis in spontaneously hypertensive rats.
    Varo N, Iraburu MJ, Varela M, López B, Etayo JC, Díez J.
    Hypertension; 2000 Jun 30; 35(6):1197-202. PubMed ID: 10856263
    [Abstract] [Full Text] [Related]

  • 17. Chronic effects of central and systemic administration of losartan on blood pressure and baroreceptor reflex in spontaneously hypertensive rats.
    Kawano Y, Yoshida K, Matsuoka H, Omae T.
    Am J Hypertens; 1994 Jun 30; 7(6):536-42. PubMed ID: 7917152
    [Abstract] [Full Text] [Related]

  • 18. Angiotensin II receptor antagonist losartan has persistent effects on blood pressure in the young spontaneously hypertensive rat: lack of relation to vascular structure.
    Morton JJ, Beattie EC, MacPherson F.
    J Vasc Res; 1992 Jun 30; 29(3):264-9. PubMed ID: 1387008
    [Abstract] [Full Text] [Related]

  • 19. Exaggerated tubuloglomerular feedback activity in genetic hypertension is mediated by ANG II and AT1 receptors.
    Brännström K, Morsing P, Arendshorst WJ.
    Am J Physiol; 1996 May 30; 270(5 Pt 2):F749-55. PubMed ID: 8928835
    [Abstract] [Full Text] [Related]

  • 20. Angiotensin II enhances integrin and alpha-actinin expression in adult rat cardiac fibroblasts.
    Kawano H, Cody RJ, Graf K, Goetze S, Kawano Y, Schnee J, Law RE, Hsueh WA.
    Hypertension; 2000 Jan 30; 35(1 Pt 2):273-9. PubMed ID: 10642310
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.